|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2101 to 2200 out of 3295 for Kras

0.018s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Bayne LJ
Year: 2012
Journal: Cancer Cell
Title: Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
Volume: 21
Issue: 6
Pages: 822-35
Publication
First Author: Terekhanova NV
Year: 2023
Journal: Nature
Title: Epigenetic regulation during cancer transitions across 11 tumour types.
Volume: 623
Issue: 7986
Pages: 432-441
Publication
First Author: Bott AJ
Year: 2015
Journal: Cell Metab
Title: Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation.
Volume: 22
Issue: 6
Pages: 1068-77
Publication
First Author: Li X
Year: 2020
Journal: Mol Cell
Title: High-Resolution In Vivo Identification of miRNA Targets by Halo-Enhanced Ago2 Pull-Down.
Volume: 79
Issue: 1
Pages: 167-179.e11
Publication
First Author: Guo JY
Year: 2013
Journal: Genes Dev
Title: Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis.
Volume: 27
Issue: 13
Pages: 1447-61
Publication
First Author: Chen F
Year: 2023
Journal: Nat Commun
Title: Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors.
Volume: 14
Issue: 1
Pages: 336
Publication
First Author: Westcott PMK
Year: 2023
Journal: Nat Genet
Title: Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity.
Volume: 55
Issue: 10
Pages: 1686-1695
Publication  
First Author: Lehman SL
Year: 2015
Journal: Sci Rep
Title: Signaling through alternative Integrated Stress Response pathways compensates for GCN2 loss in a mouse model of soft tissue sarcoma.
Volume: 5
Pages: 11781
Publication
First Author: Herzog BH
Year: 2023
Journal: Sci Transl Med
Title: Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer.
Volume: 15
Issue: 699
Pages: eadh8005
Publication
First Author: Hildebrand KM
Year: 2021
Journal: PLoS One
Title: The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Volume: 16
Issue: 7
Pages: e0253864
Publication
First Author: Revenco T
Year: 2019
Journal: Cell Rep
Title: Context Dependency of Epithelial-to-Mesenchymal Transition for Metastasis.
Volume: 29
Issue: 6
Pages: 1458-1468.e3
Publication
First Author: Magkrioti C
Year: 2018
Journal: Cancer Res
Title: The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Volume: 78
Issue: 13
Pages: 3634-3644
Publication
First Author: Douguet L
Year: 2021
Journal: Nat Commun
Title: A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.
Volume: 12
Issue: 1
Pages: 653
Publication
First Author: Zhang Y
Year: 2013
Journal: Cancer Res
Title: Canonical wnt signaling is required for pancreatic carcinogenesis.
Volume: 73
Issue: 15
Pages: 4909-22
Publication
First Author: McLoed AG
Year: 2016
Journal: Cell Rep
Title: Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer.
Volume: 16
Issue: 1
Pages: 120-132
Publication
First Author: Jang JW
Year: 2006
Journal: Mol Cell Biol
Title: Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis.
Volume: 26
Issue: 21
Pages: 8109-21
Publication
First Author: Zhu L
Year: 2019
Journal: Nat Cell Biol
Title: TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis.
Volume: 21
Issue: 12
Pages: 1604-1614
Publication  
First Author: Kim TH
Year: 2010
Journal: J Oncol
Title: The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action.
Volume: 2010
Pages: 139087
Publication
First Author: Li R
Year: 2017
Journal: Cancer Res
Title: Modulation of Bax and mTOR for Cancer Therapeutics.
Volume: 77
Issue: 11
Pages: 3001-3012
Publication  
First Author: Volonte D
Year: 2021
Journal: J Biol Chem
Title: Cell autonomous angiotensin II signaling controls the pleiotropic functions of oncogenic K-Ras.
Volume: 296
Pages: 100242
Publication
First Author: Hollander MC
Year: 2011
Journal: Oncogene
Title: Akt1 deletion prevents lung tumorigenesis by mutant K-ras.
Volume: 30
Issue: 15
Pages: 1812-21
Publication
First Author: Andricovich J
Year: 2016
Journal: J Clin Invest
Title: Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.
Volume: 126
Issue: 3
Pages: 905-20
Publication
First Author: Yang Y
Year: 2014
Journal: J Clin Invest
Title: ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
Volume: 124
Issue: 6
Pages: 2696-708
Publication
First Author: Liu Y
Year: 2014
Journal: J Biol Chem
Title: The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
Volume: 289
Issue: 7
Pages: 4116-25
Publication
First Author: Baker DJ
Year: 2013
Journal: Nat Cell Biol
Title: Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan.
Volume: 15
Issue: 1
Pages: 96-102
Publication
First Author: Hidalgo-Sastre A
Year: 2016
Journal: Am J Pathol
Title: Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
Volume: 186
Issue: 11
Pages: 2934-2944
Publication
First Author: Ruscetti M
Year: 2015
Journal: Cancer Res
Title: Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis.
Volume: 75
Issue: 13
Pages: 2749-59
Publication
First Author: Tshering LF
Year: 2023
Journal: Dev Cell
Title: Immune mechanisms shape the clonal landscape during early progression of prostate cancer.
Volume: 58
Issue: 12
Pages: 1071-1086.e8
Publication
First Author: Hill R
Year: 2012
Journal: Mol Cancer Ther
Title: Cell intrinsic role of COX-2 in pancreatic cancer development.
Volume: 11
Issue: 10
Pages: 2127-37
Publication
First Author: Weizman N
Year: 2014
Journal: Oncogene
Title: Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.
Volume: 33
Issue: 29
Pages: 3812-9
Publication  
First Author: Dixit A
Year: 2022
Journal: JCI Insight
Title: Targeting TNF-α-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling.
Volume: 7
Issue: 22
Publication
First Author: Renz BW
Year: 2018
Journal: Cancer Discov
Title: Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.
Volume: 8
Issue: 11
Pages: 1458-1473
Publication
First Author: Amit M
Year: 2016
Journal: Nat Rev Cancer
Title: Mechanisms of cancer dissemination along nerves.
Volume: 16
Issue: 6
Pages: 399-408
Publication
First Author: Wen Z
Year: 2022
Journal: Leukemia
Title: Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice.
Volume: 36
Issue: 4
Pages: 1167-1170
Publication
First Author: Gams A
Year: 2023
Journal: Physiol Rep
Title: Evidence of sex differences in cancer-related cardiac complications in mouse models of pancreatic and liver cancer.
Volume: 11
Issue: 8
Pages: e15672
Publication
First Author: Nabeshima T
Year: 2020
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma.
Volume: 318
Issue: 3
Pages: G419-G427
Publication
First Author: Yang S
Year: 2016
Journal: Cancer Res
Title: A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Volume: 76
Issue: 13
Pages: 3838-50
Publication
First Author: Vogel KS
Year: 2000
Journal: Mol Cell Neurosci
Title: Neurofibromin negatively regulates neurotrophin signaling through p21ras in embryonic sensory neurons.
Volume: 15
Issue: 4
Pages: 398-407
Publication
First Author: Meyers N
Year: 2020
Journal: Sci Rep
Title: Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma.
Volume: 10
Issue: 1
Pages: 5241
Publication  
First Author: Choueiry F
Year: 2020
Journal: J Immunother Cancer
Title: CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Volume: 8
Issue: 1
Publication
First Author: Mace TA
Year: 2018
Journal: Gut
Title: IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
Volume: 67
Issue: 2
Pages: 320-332
Publication
First Author: Walz S
Year: 2014
Journal: Nature
Title: Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles.
Volume: 511
Issue: 7510
Pages: 483-7
Publication  
First Author: Markosyan N
Year: 2019
Journal: J Clin Invest
Title: Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2).
Volume: 130
Pages: 3594-3609
Publication
First Author: Su J
Year: 2020
Journal: Nature
Title: TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
Volume: 577
Issue: 7791
Pages: 566-571
Publication
First Author: Sato T
Year: 2017
Journal: Cancer Sci
Title: c-Jun N-terminal kinase in pancreatic tumor stroma augments tumor development in mice.
Volume: 108
Issue: 11
Pages: 2156-2165
Publication
First Author: Zhang AMY
Year: 2023
Journal: Cell Metab
Title: Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation.
Volume: 35
Issue: 12
Pages: 2119-2135.e5
Publication
First Author: Kalisz M
Year: 2020
Journal: EMBO J
Title: HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer.
Volume: 39
Issue: 9
Pages: e102808
Publication
First Author: Miyabayashi K
Year: 2013
Journal: Cancer Res
Title: Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals.
Volume: 73
Issue: 7
Pages: 2221-34
Publication
First Author: Wang Y
Year: 2019
Journal: Cancer Res
Title: Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Volume: 79
Issue: 17
Pages: 4466-4479
Publication  
First Author: Kishikawa T
Year: 2016
Journal: Nat Commun
Title: Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.
Volume: 7
Pages: 13006
Publication
First Author: Özdemir BC
Year: 2014
Journal: Cancer Cell
Title: Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
Volume: 25
Issue: 6
Pages: 719-34
Publication
First Author: Dosch AR
Year: 2020
Journal: Mol Cancer Res
Title: Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer.
Volume: 18
Issue: 4
Pages: 623-631
Publication
First Author: Takahashi R
Year: 2020
Journal: Sci Rep
Title: Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.
Volume: 10
Issue: 1
Pages: 21194
Publication
First Author: Dias DO
Year: 2021
Journal: Nat Commun
Title: Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions.
Volume: 12
Issue: 1
Pages: 5501
Publication
First Author: Holl D
Year: 2024
Journal: Nat Neurosci
Title: Distinct origin and region-dependent contribution of stromal fibroblasts to fibrosis following traumatic injury in mice.
Volume: 27
Issue: 7
Pages: 1285-1298
Publication
First Author: Dias DO
Year: 2018
Journal: Cell
Title: Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury.
Volume: 173
Issue: 1
Pages: 153-165.e22
Publication
First Author: Göritz C
Year: 2011
Journal: Science
Title: A pericyte origin of spinal cord scar tissue.
Volume: 333
Issue: 6039
Pages: 238-42
Publication
First Author: Hamada S
Year: 2018
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
Volume: 314
Issue: 1
Pages: G65-G74
Publication
First Author: DeNicola GM
Year: 2011
Journal: Nature
Title: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
Volume: 475
Issue: 7354
Pages: 106-9
Publication
First Author: Chung WC
Year: 2020
Journal: Am J Pathol
Title: PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer.
Volume: 190
Issue: 11
Pages: 2194-2202
Publication
First Author: Fang X
Year: 2015
Journal: Prostate
Title: Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate.
Volume: 75
Issue: 9
Pages: 988-1000
Publication  
First Author: Liu TW
Year: 2021
Journal: Cells
Title: Multi-Modal Multi-Spectral Intravital Macroscopic Imaging of Signaling Dynamics in Real Time during Tumor-Immune Interactions.
Volume: 10
Issue: 3
Publication
First Author: Berent-Maoz B
Year: 2015
Journal: PLoS One
Title: The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2).
Volume: 10
Issue: 5
Pages: e0125414
Publication
First Author: Gorentla BK
Year: 2013
Journal: J Immunol
Title: Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis.
Volume: 190
Issue: 3
Pages: 1026-37
Publication
First Author: Title AC
Year: 2018
Journal: Nat Commun
Title: Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion.
Volume: 9
Issue: 1
Pages: 4671
Publication
First Author: Grüner BM
Year: 2012
Journal: PLoS One
Title: MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Volume: 7
Issue: 6
Pages: e39424
Publication
First Author: Zambirinis CP
Year: 2015
Journal: J Exp Med
Title: TLR9 ligation in pancreatic stellate cells promotes tumorigenesis.
Volume: 212
Issue: 12
Pages: 2077-94
Publication
First Author: Rielland M
Year: 2014
Journal: J Clin Invest
Title: Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
Volume: 124
Issue: 5
Pages: 2125-35
Publication
First Author: Zolghadri Y
Year: 2018
Journal: Am J Pathol
Title: Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth.
Volume: 188
Issue: 3
Pages: 616-626
Publication
First Author: DelGiorno KE
Year: 2020
Journal: Gastroenterology
Title: Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2.
Volume: 159
Issue: 5
Pages: 1866-1881.e8
Publication
First Author: Zhao Y
Year: 2020
Journal: Cancer Res
Title: Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
Volume: 80
Issue: 16
Pages: 3359-3371
Publication
First Author: Zhou R
Year: 2016
Journal: Oncogene
Title: A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Volume: 35
Issue: 43
Pages: 5608-5618
Publication
First Author: Principe DR
Year: 2016
Journal: Cancer Res
Title: TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis.
Volume: 76
Issue: 9
Pages: 2525-39
Publication
First Author: Ostapoff KT
Year: 2014
Journal: Cancer Res
Title: Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.
Volume: 74
Issue: 18
Pages: 4996-5007
Publication
First Author: Zhang Y
Year: 2019
Journal: Mol Cancer Res
Title: Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer.
Volume: 17
Issue: 2
Pages: 348-355
Publication
First Author: Xu Z
Year: 2023
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Farnesoid X receptor activation inhibits pancreatic carcinogenesis.
Volume: 1869
Issue: 7
Pages: 166811
Publication
First Author: Ludwig KF
Year: 2018
Journal: Cancer Res
Title: Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.
Volume: 78
Issue: 1
Pages: 246-255
Publication
First Author: Jang JE
Year: 2017
Journal: Cell Rep
Title: Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.
Volume: 20
Issue: 3
Pages: 558-571
Publication
First Author: Sahraei M
Year: 2012
Journal: Oncogene
Title: MUC1 regulates PDGFA expression during pancreatic cancer progression.
Volume: 31
Issue: 47
Pages: 4935-45
Publication
First Author: Perkhofer L
Year: 2017
Journal: Cancer Res
Title: ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.
Volume: 77
Issue: 20
Pages: 5576-5590
Publication    
First Author: Pandey V
Year: 2021
Journal: Elife
Title: CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions.
Volume: 10
Publication
First Author: Criscimanna A
Year: 2013
Journal: Cancer Res
Title: PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis.
Volume: 73
Issue: 15
Pages: 4781-90
Publication  
First Author: Zhou L
Year: 2018
Journal: Sci Transl Med
Title: Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.
Volume: 10
Issue: 464
Publication
First Author: Wang M
Year: 2015
Journal: Cancer Res
Title: Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.
Volume: 75
Issue: 23
Pages: 5058-69
Publication  
First Author: Kibe S
Year: 2019
Journal: Cancer Lett
Title: Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion.
Volume: 444
Pages: 70-81
Publication
First Author: Driscoll DR
Year: 2016
Journal: Cancer Res
Title: mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.
Volume: 76
Issue: 23
Pages: 6911-6923
Publication
First Author: Besmer DM
Year: 2011
Journal: Cancer Res
Title: Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis.
Volume: 71
Issue: 13
Pages: 4432-42
Publication
First Author: Mohammed A
Year: 2015
Journal: Oncotarget
Title: Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression.
Volume: 6
Issue: 17
Pages: 15524-39
Publication
First Author: Zhang W
Year: 2015
Journal: Cancer Res
Title: YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
Volume: 75
Issue: 21
Pages: 4450-7
Publication
First Author: Li F
Year: 2015
Journal: Cancer Cell
Title: LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.
Volume: 27
Issue: 5
Pages: 698-711
Publication  
First Author: Xue Y
Year: 2024
Journal: J Exp Med
Title: TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition.
Volume: 221
Issue: 7
Publication
First Author: Elyada E
Year: 2019
Journal: Cancer Discov
Title: Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.
Volume: 9
Issue: 8
Pages: 1102-1123
Publication
First Author: Ruggeri JM
Year: 2020
Journal: Am J Pathol
Title: Discoidin Domain Receptor 1 (DDR1) Is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma.
Volume: 190
Issue: 8
Pages: 1735-1751
Publication  
First Author: Jain R
Year: 2015
Journal: Nat Commun
Title: Plasticity of Hopx(+) type I alveolar cells to regenerate type II cells in the lung.
Volume: 6
Pages: 6727
Publication
First Author: Michael IP
Year: 2019
Journal: Dev Cell
Title: ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.
Volume: 49
Issue: 3
Pages: 409-424.e6
Publication
First Author: Dail M
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.
Volume: 107
Issue: 11
Pages: 5106-11
Publication
First Author: Schoeps B
Year: 2021
Journal: Cancer Res
Title: TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
Volume: 81
Issue: 13
Pages: 3568-3579
Publication
First Author: Bhatt V
Year: 2019
Journal: Genes Dev
Title: Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis.
Volume: 33
Issue: 3-4
Pages: 150-165
Publication
First Author: Long JS
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis.
Volume: 119
Issue: 28
Pages: e2113465119
Publication
First Author: Postler TS
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: A pan-cancer analysis implicates human NKIRAS1 as a tumor-suppressor gene.
Volume: 120
Issue: 46
Pages: e2312595120